๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
AC Immune SA (ACIU)
NASDAQ: ACIU ยท Real-Time Price ยท USD
1.950
-0.180 (-8.45%)
Nov 20, 2026, 4:00 PM EST - Market closed

AC Immune Financials Overview

Millions CHF. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
19.813.5727.3114.83.94-
Revenue Growth
353.20%-86.92%84.51%276.14%--
Gross Profit
-22.88-52.86-35.26-39.81-56.4-62.28
Operating Income
-37.8-68.86-52.38-53.62-70.85-79.01
Net Income
-36.05-70.45-50.92-54.23-70.75-73
Earnings Per Share
-0.35-0.70-0.51-0.64-0.85-0.97
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
73.9191.41165.49103.05122.59198.22
Total Debt
3.94.545.433.52.82.91
Net Cash (Debt)
70.0286.87160.0699.55119.79195.31
Net Cash Growth
-32.55%-45.73%60.78%-16.89%-38.67%-12.68%
Net Cash Per Share
0.680.861.611.181.432.61

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
--69.2665.84-60.41-73.57-65.69
Capital Expenditures
--0.9-0.58-0.8-1.24-2.64
Free Cash Flow
--70.1665.27-61.21-74.81-68.32
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-115.49%--129.12%-268.94%--
Operating Margin
-190.79%-1927.32%-191.80%-362.30%-1800.43%-
Pretax Margin
-181.95%-1971.65%-186.43%-366.35%-1797.71%-
Profit Margin
-181.95%-1971.65%-186.44%-366.41%-1798.04%-
FCF Margin
--1963.67%238.99%-413.55%-1901.07%-

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
17.1714.2114.2166.3866.3866.38
P/FCF Ratio
--3.71---
PS Ratio
8.1668.958.8628.1137.03-